StonvexLoading…
StonvexCore line items from BY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $572.22M | $565.93M | $479.48M | $301.56M |
Operating Income | $173.25M | $161.08M | $145.68M | $114.68M |
Net Income | $130.05M | $120.76M | $107.88M | $87.95M |
EPS (Diluted) | $2.89 | $2.75 | $2.67 | $2.34 |
Total Assets | $9.65B | $9.50B | $8.88B | $7.36B |
Total Liabilities | $8.38B | $8.41B | $7.89B | $6.60B |
Cash & Equivalents | $149.09M | $563.14M | $226.14M | $179.35M |
Free Cash Flow OCF − CapEx | $136.32M | $171.17M | $162.21M | $216.70M |
Shares Outstanding | 45.55M | 44.46M | 43.76M | 37.49M |